Komori
Semiannual Report7096StemCell InstituteServices

Semiannual Report — FY2026 H1

What StemCell Institute reported for the period from 2026-04-01 to 2027-03-31.

How much it says
56Typical
What moved here
19named for the first time
Its own wording
25terms
Which filing this is
17/ 17newest
No officer data yetThis company's filings have not been read for officers yet. Nothing is missing from the filings — the roster simply has not been extracted.
The gist

During the current interim consolidated accounting period, the cell bank business advanced its initiatives in Japan and overseas, including revising its pricing structure and strengthening events and information dissemination in Japan, and progressing the review procedures toward completion of CPC/CCC and acquisition of an MOH licence overseas, in Singapore. Meanwhile, net sales decreased slightly year on year, while operating profit, ordinary profit and interim net income attributable to owners of the parent all declined.

Komori's summary of this document, not the document's own words.
56Typical
How much this filing saysA weighted roll-up of 10 rubric dimensions, each scored from a fixed set of questions asked against this filing — built only from the 33 this document could answer. It measures how specific the disclosure is, not whether the company is doing well. Derived from the data, not editorial.
73
Detailed
Magnitude of change
30
Thin
Strategic shift
88
Very detailed
Capital movements
50
Typical
Disclosure gaps
15
Almost nothing
Future commitments
68
Detailed
Change in risk
71
Detailed
Financial and capital policy
53
Typical
Product portfolio
79
Very detailed
Technology position
32
Thin
Confidence in strategic bets
R&D spend4百万円Money spent making new things.
Cash left over-5億円Cash from the business, less what went into equipment.
Spent on equipment4億円Plants, machines — things meant to last.
EmployeesNot disclosedThis document does not carry the figure.
How to read this page
This is not the documentIt is Komori's reading of the filing submitted to EDINET. The original is linked above.
The score is not a verdictIt measures how specific the disclosure is. It says nothing about results or where the share price goes.
When it updatesContent lands once the filing has been read through. Right after submission, the summary can still be empty.